Reports

• North Carolina Did Not Comply With Federal and State Requirements When Making Medicaid Cost-Sharing Payments for Professional Medical Services

  

• Ohio Claimed Unallowable Federal Reimbursement for Some Medicaid Physician-Administered Drugs

  

• Oklahoma Did Not Correctly Process Adjustments to Medicare Crossover Claims

  

• New York Did Not Always Verify Correction of Deficiencies Identified During Surveys of Nursing Homes Participating in Medicare and Medicaid

  

• Kansas Received Millions in Unallowable Bonus Payments

  

• Ohio Received Millions in Unallowable Bonus Payments

  

• First Coast Service Options, Inc., Generally Claimed Allowable Medicare Pension Costs

  

• CMS Ensured Nearly All Part D Drug Records Contained Valid Prescriber Identifiers in 2016

  

• Testimony of James A. Cannatti III

  

• Review of The Department of Health and Human Services (HHS) Cancellation of Marketplace Enrollment Outreach Efforts

  

• HRSA Complied With Federal and HHS Grant Policies When Awarding Zika Response and Preparedness Appropriations Act Funds During Fiscal Year 2017

  

• CMS Ensured That Medicare Shared Savings Program Beneficiaries Were Properly Assigned: Beneficiaries Were Assigned to Only One Accountable Care Organization and Were Not Assigned to Other Shared Savings Programs

  

• Wisconsin Physicians Service Insurance Corporation Claimed Unallowable Medicare Part B Administrative Costs for Fiscal Year 2012

  

• National Government Services Properly Claimed Allowable Administrative Costs for the Last Three Quarters of Fiscal Years 2011 and 2012 Under Medicare Contract 00630

  

• National Government Services Properly Claimed Allowable Administrative Costs for the Last Three Quarters of Fiscal Years 2011 and 2012 Under Medicare Contract 00130

  

• National Government Services Properly Claimed Allowable Administrative Costs for the Last Three Quarters of Fiscal Years 2011 and 2012 Under Medicare Contract 00450

  

• Medicare Payments for Clinical Diagnostic Laboratory Tests in 2016: Year 3 of Baseline Data

  

• Shortcomings of Device Claims Data Complicate and Potentially Increase Medicare Costs for Recalled and Prematurely Failed Devices

  

• Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2015 Average Sales Prices

  

• A Few States Fell Short in Timely Investigation of the Most Serious Nursing Home Complaints: 2011-2015